Nivolumab with definitive chemoradiotherapy for oesophageal squamous cell carcinoma (NOBEL): a multicentre, single-arm, phase 2 feasibility trial

Authors

Juko Shimizu
Akinori Watanabe (ORCID: https://orcid.org/0009-0001-2434-8023)
Shinya Ohashi (ORCID: https://orcid.org/0000-0003-1776-4309)
Keiko Minashi (ORCID: https://orcid.org/0000-0003-1513-7117)
Ihhwa Kim
Harue Tada (ORCID: https://orcid.org/0000-0001-8634-5592)
Yusuke Amanuma
Kengo Nagashima
Takashi Kojima
Ken Kato
Manabu Muto
Chikatoshi Katada
Akiyoshi Nakakura
Katsuyuki Sakanaka
Motoo Nomura

Institutions

Kyoto University (JP)
Keio University Hospital (JP)
Chiba Cancer Center (JP)
National Cancer Center Hospital East (JP)
Kyoto University Hospital (JP)
Kitasato University (JP)

Publication Details

Journal: EClinicalMedicine
Published: 2025-12-27
DOI: https://doi.org/10.1016/j.eclinm.2025.103689
Citations: 1
Primary Topic: Esophageal Cancer Research and Treatment
Type: article
Field-Weighted Citation Impact: 2.01

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Nivolumab with definitive chemoradiotherapy for oesophageal squamous cell carcinoma (NOBEL): a multicentre, single-arm, phase 2 feasibility trial

Juko Shimizu, Akinori Watanabe, Shinya Ohashi, Keiko Minashi et al.

Dec 27, 2025

1 citations

EClinicalMedicine

Esophageal Cancer Research and Treatment

2.01

article

Nivolumab with definitive chemoradiotherapy for oesophageal squamous cell carcinoma (NOBEL): a multicentre, single-arm, phase 2 feasibility trial

Juko Shimizu, Akinori Watanabe, Shinya Ohashi, Keiko Minashi, Ihhwa Kim, Harue Tada, Yusuke Amanuma, Kengo Nagashima, Takashi Kojima, Ken Kato, Manabu Muto, Chikatoshi Katada, Akiyoshi Nakakura, Katsuyuki Sakanaka, Motoo Nomura

December 27, 2025article en

1 citations

Abstract

No abstract available for this paper.

EClinicalMedicineVol. 91

Kyoto University (JP), Keio University Hospital (JP), Chiba Cancer Center (JP), National Cancer Center Hospital East (JP), Kyoto University Hospital (JP), Kitasato University (JP)

Good health and well-being

Openalex Percentile: Top 10%

Esophageal Cancer Research and Treatment

2.01

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.